Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

K-STAR (Kremezin STudy Against Renal Disease Progression in Korea) Randomized, Open-label, Controlled Study

NCT00860431 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT00860431
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00860431 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
K-STAR (Kremezin STudy Against Renal Disease Progression in Korea) Randomized, Open-label, Controlled Study
Lead sponsor
Seoul National University Hospital
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2009
Completion date
September 30, 2013
Enrollment
578 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease